Join the club for FREE to access the whole archive and other member benefits.

Matthew Hirschey

Associate Professor in the Departments of Medicine and Pharmacology & Cancer Biology at Duke University

His research focuses on mitochondrial metabolism, with a particular interest in how cells use metabolites and chemical modifications to sense metabolism. He and his lab study the regulation of this process by a family of enzymes called sirtuins, and how sirtuins maintain energy homeostasis. His work has appeared in several leading journals, including Nature, Science, Cell Metabolism and Molecular Cell. He has received several awards including an Innovator Award from the American Heart Association, a New Scholar in Aging Award from the Ellison Medical Foundation, and the Helmholtz Young Investigator in Diabetes (HeIDi) Award.

The Hirschey Lab in the Duke Molecular Physiology Institute, and the Departments of Medicine and Pharmacology & Cancer Biology at Duke University studies different aspects of metabolic control, mitochondrial signaling, and cellular processes regulating human health and disease.

He's also a Scientific Advisory Board Member at Genflow Biosciences.

https://www.hirscheylab.org/

Visit website: https://www.matthewhirschey.com/

 MattheWhirschey

See also: Academia Duke University School of Medicine - Top Medical School, Duke University

Matthew Hirschey is also referenced in the following:

Genflow Biosciences

Developing medicines that potentially halt, slow or reverse the aging process

Matthew Hirschey Blog Posts

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy
16-Jul-2020

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy

Great to see a startup willing to explicitly state they are treating ageing itself as a disease